Cargando…
Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial
BACKGROUND: Randomized trials are generally performed from a frequentist perspective, which can conflate absence of evidence with evidence of absence. The RECOVERY trial evaluated convalescent plasma for patients hospitalized with coronavirus disease 2019 (COVID-19) and concluded that there was no e...
Autores principales: | Hamilton, F.W., Lee, Todd, Arnold, D.T., Lilford, R., Hemming, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214317/ https://www.ncbi.nlm.nih.gov/pubmed/34157385 http://dx.doi.org/10.1016/j.ijid.2021.06.034 |
Ejemplares similares
-
Interpreting a Bayesian phase II futility clinical trial
por: Beall, Jonathan, et al.
Publicado: (2022) -
Photorespiration: The Futile Cycle?
por: Shi, Xiaoxiao, et al.
Publicado: (2021) -
Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial
por: Chen, Dung-Tsa, et al.
Publicado: (2019) -
The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor–Positive Breast Cancer
por: Lohmann, Ana Elisa, et al.
Publicado: (2022) -
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
por: Bégin, Philippe, et al.
Publicado: (2021)